Ads
related to: sickle cell anemia- Safety and Side Effects
Review the Important Safety
Information for this treatment.
- Patient Resources
See the discussion guides, FAQs,
support groups and more.
- Treatment Journey Video
Understand the steps
and what they entail.
- Learn How It Works
Visit the official patient site to
learn how this treatment works.
- About The Therapy
Learn how this therapy may help
treat the disease. Watch the video.
- Sign Up
Sign up today to get connected
with a Patient Educator.
- Safety and Side Effects
temu.com has been visited by 1M+ users in the past month
Search results
Results From The WOW.Com Content Network
Hematology. Diamond–Blackfan anemia ( DBA) is a congenital erythroid aplasia that usually presents in infancy. [3] DBA causes low red blood cell counts ( anemia ), without substantially affecting the other blood components (the platelets and the white blood cells ), which are usually normal. This is in contrast to Shwachman–Bodian–Diamond ...
Transfusion therapy for sickle-cell disease entails the use of red blood cell transfusions in the management of acute cases of sickle cell disease and as a prophylaxis to prevent complications by decreasing the number of red blood cells (RBC) that can sickle by adding normal red blood cells. [citation needed]
Sickle cell anemia. An example of overdominance in humans is that of the sickle cell anemia. This condition is determined by a single polymorphism. Possessors of the deleterious allele have lower life expectancy, with homozygotes rarely reaching 50 years of age. However, this allele also yields some resistance to malaria. Thus in regions where ...
Autosplenectomy caused by sickle cell anemia or hyposplenism in coeliac disease; In patients with obstructive liver disease, lecithin cholesterol acetyltransferase activity is depressed, which increases the cholesterol-to-phospholipid ratio and produces an absolute increase in the surface area of the red cell membrane.
Normocytic anemia. Normocytic anemia is a type of anemia and is a common issue that occurs for men and women typically over 85 years old. Its prevalence increases with age, reaching 44 percent in men older than 85 years. [1] The most common type of normocytic anemia is anemia of chronic disease. [1]
The types of anemia treated with drugs are iron-deficiency anemia, thalassemia, aplastic anemia, hemolytic anemia, sickle cell anemia, and pernicious anemia, the most important of them being deficiency and sickle cell anemia with together 60% of market share because of highest prevalence as well as higher treatment costs compared with other types.
Ad
related to: sickle cell anemia